PRIA Logo™
DelawareSB 120153rd General Assembly (2024–2026)SenateWALLET

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

Sponsored By: Spiros Mantzavinos (Democratic)

Failed

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Delaware patients gain coverage for biomarker tests

The law requires biomarker testing coverage in Delaware individual, group, state employee, and public assistance health plans. It applies to policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued after December 31, 2026. Biomarker tests check tissue, blood, or other samples for signs such as gene changes or protein levels. Covered tests must help diagnose, treat, manage, or monitor a disease or condition and have medical and scientific support. Evidence includes FDA-approved or cleared test uses, FDA-approved drug indications or label warnings, Medicare coverage decisions, or recognized clinical guidelines or consensus statements. Plans must limit care disruptions, including minimizing repeat biopsies or sample collection. Individual and group policies can keep deductibles, coinsurance, allowed-charge limits, and rules coordinating payments with other coverage. The mandate excludes accident-only, specified-disease, hospital indemnity, Medicare supplement, long-term care, disability income, and other limited-benefit policies.

Sponsors & Cosponsors

Sponsor

  • Spiros Mantzavinos

    Democratic • Senate

Cosponsors

  • Alonna Berry

    Democratic • House

  • William Bush

    Democratic • House

  • Daniel Cruce

    Democratic • Senate

  • Mara Gorman

    Democratic • House

  • Stephanie L. Hansen

    Democratic • Senate

  • Kyra L. Hoffner

    Democratic • Senate

  • Eric Morrison

    Democratic • House

  • Ray Seigfried

    Democratic • Senate

  • John "Jack" Walsh

    Democratic • Senate

  • David L. Wilson

    Republican • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. SS 1 for SB 120 - Signed by Governor

    9/8/2026Governor

  2. SS 1 for SB 120 - Passed By House. Votes: 40 YES 1 ABSENT

    7/1/2026House

  3. SS 1 for SB 120 - Reported Out of Committee (Appropriations) in House with 4 On Its Merits

    6/23/2026House

  4. SS 1 for SB 120 - Assigned to Appropriations Committee in House

    6/16/2026House

  5. SS 1 for SB 120 - Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 2 Favorable, 7 On Its Merits

    6/16/2026House

  6. SS 1 for SB 120 - Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

    6/11/2026House

  7. SS 1 for SB 120 - Passed By Senate. Votes: 20 YES 1 ABSENT

    6/10/2026Senate

  8. SS 1 for SB 120 - Reported Out of Committee (Finance) in Senate with 4 On Its Merits

    6/9/2026Senate

  9. SS 1 for SB 120 - Assigned to Finance Committee in Senate

    4/22/2026Senate

  10. SS 1 for SB 120 - Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 Favorable

    4/22/2026Senate

  11. Substituted in Senate by SS 1 for SB 120

    4/13/2026Senate

  12. Introduced and Assigned to Banking, Business, Insurance & Technology Committee in Senate

    5/1/2025Senate

Bill Text

Related Bills

Back to State Legislation